The drug is currently in a Phase 1 clinical trial. MM+M spoke with Anixa chairman and CEO Amit Kumar about the latest developments in the breast cancer vaccine as well as advancements in the broader ...

SAN JOSE, Calif., Feb. 4, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today ...